HUBUNGAN TINGKAT KEPATUHAN TERAPI ANTIHIPERTENSI DENGAN RISIKO KARDIOVASKULAR DI PUSKESMAS CIKARANG

Rahmi Anggita; Marselina; Nuzul Gyanata Adwisastra; Masita Sari Dewi

doi:10.36805/jbf.v5i3.1511

Rahmi Anggita Universitas Medika Suherman, Bekasi, Indonesia
Marselina Universitas Medika Suherman, Bekasi, Indonesia
Nuzul Gyanata Adwisastra Universitas Medika Suherman, Bekasi, Indonesia
Masita Sari Dewi Universitas Medika Suherman, Bekasi, Indonesia

DOI: https://doi.org/10.36805/jbf.v5i3.1511

Keywords: adherence, ASCVD, MARS-5, clinical pharmacy, Cardiovascular

Abstract

Hypertension is a major risk factor for cardiovascular disease. However, evidence regarding the association between adherence to antihypertensive therapy and cardiovascular risk remains inconsistent, particularly in primary care settings. This study was conducted at Cikarang Community Health Center, where hypertension is among the top ten most prevalent diseases. The objective was to determine the relationship between adherence to antihypertensive therapy and cardiovascular risk. A cross-sectional analytical study was conducted on 85 purposively selected hypertensive patients. Adherence was assessed using MARS-5 and Medication Possession Ratio (MPR), while cardiovascular risk was calculated with the ASCVD score. Data were analyzed using Chi-Square, linearity test, and Odds Ratio. Results showed that most patients were adherent (MARS-5 = 91.8%; MPR = 76.5%) and had low cardiovascular risk (64.7%). There was a significant association between adherence and cardiovascular risk (MARS-5 p=0.041; MPR p=0.049). Adherent patients were more likely to have lower cardiovascular risk. In conclusion, higher adherence is associated with lower cardiovascular risk. Continuous education and routine monitoring are essential to maintain adherence and prevent complications.

References

Arwinda, P., Virginia, D. M., & Hendra, P. (2024).

Pengaruh Kepatuhan Terapi Antihipertensi Terhadap Risiko Kardiovaskular Pada Penderita Hipertensi Di Kabupaten Purworejo. Jurnal Farmasi dan Sains, 21(2):90–199.

Cahyani, A. R., & Widyastuti, F. Y. (2022). Hubungan Medication Possession Ratio (MPR) dengan pengendalian tekanan darah pasien hipertensi di Puskesmas Gayamsari Kota Semarang. Jurnal Medika, 10(2), 102–108.

Dinas Kesehatan Kabupaten Bekasi. (2022). Profil Kesehatan Kabupaten Bekasi Tahun 2021. Bekasi: Dinkes Kabupaten Bekasi.

Kementerian Kesehatan RI. (2023). Profil Kesehatan Indonesia 2022. Jakarta: Kemenkes RI.

Pranawa, B. P. (2018). Penyakit Kardiovaskular. Yogyakarta: Adji Prayitno.

Pratiwi, V. D., & Virginia, D. M. (2023). Ketaatan

Terapi Antihipertensi Dengan Terkontrolnya Tekanan Darah Pada Pasien Hipertensi Dengan Komorbid DM Tipe 2. Jurnal Farmasi Sleman, 5(1): 45–53.

WHO. (2023). Hypertension. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/hypertension

Yanti, A. R., Sari, D. K., & Mulyani, H. (2020). Faktor Risiko Hipertensi Dan Implikasinya Pada Penyakit Kardiovaskular. Jurnal Keperawatan Indonesia, 23(1):12–19.

Ismayadi, A., Prasetyo, W., & Nugroho, S. (2022). Prevalensi Hipertensi Pada Lansia Dan Faktor Risikonya. Jurnal Kesehatan Masyarakat, 18(2):87–95.

Burnier, M., & Egan, B. M. (2019). Adherence In Hypertension: A Review Of Prevalence, Risk Factors, Impact, And Management. Circulation Research, 124(7):1124–1140.

GBD 2021 Risk Factors Collaborators. (2022). Global Burden Of Hypertension And Associated Risk Factors, 1990–2019: A Systematic Analysis. The Lancet, 400(10364):122–141.

Chowdhury, E. K., et al. (2021). Medication Adherence And Cardiovascular Outcomes In Hypertensive Patients: A Systematic Review. American Journal of Hypertension, 34(8):795–805.

Whelton, P. K., Carey, R. M., & Aronow, W. S. (2018). 2017 ACC/AHA/AAPA Guideline For The Prevention, Detection, Evaluation, And Management Of High Blood Pressure In Adults. Journal of the American College of Cardiology, 71(19):127–e248.

Vrijens, B., Antoniou, S., Burnier, M., de la Sierra, A., & Volpe, M. (2017). Current Situation Of Medication Adherence In Hypertension. Frontiers in Pharmacology, 8, 100.

Prinsen, A., et al. (2024). Validity And Reliability Of the Medication Adherence Report Scale (MARS-5) in a Southeastern European population. International Journal of Clinical Pharmacy, 46(3):502–510.

De Geest, S., Zullig, L. L., Dunbar-Jacob, J., Helmy, R., Hughes, D. A., Wilson, I. B., & Vrijens, B. (2018). ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Annals of Internal Medicine, 169(1):30–35.

Abegaz, T. M., Shehab, A., Gebreyohannes, E. A., Bhagavathula, A. S., & Elnour, A. A. (2017). Nonadherence to Antihypertensive Drugs: A Systematic Review And Meta-Analysis. Medicine, 96(4):5641.

Williams, B., et al. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal, 39(33):3021–3104.

Lee, H. Y., et al. (2020). Adherence To Antihypertensive Medication And Cardiovascular Disease In Korean Patients. Hypertension Research, 43(7):619–628.

Hwang, B., et al. (2021). Association Between Adherence To Antihypertensive Medications And Cardiovascular Events In Asian Populations: A Cohort Study. Journal of Hypertension, 39(4):789–797.

Sapkota, S., et al. (2022). Factors Affecting Antihypertensive Medication Adherence In Low- And Middle-Income Countries: A Systematic Review. BMC Public Health, 22, 1182.

Ettehad, D., et al. (2016). Blood Pressure Lowering For Prevention Of Cardiovascular Disease And Death: A Systematic Review And Meta-Analysis. The Lancet, 387(10022):957–967.